
CAS Name: 8-[4,4-Bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-oneTrademarks: Imap (McNeil); Redeptin (SK F)
Percent Composition: C 73.24%, H 6.57%, F 7.99%, N 8.84%, O 3.36...
Literature References: Prepn: BE 633914; P. A. J. Janssen, US 3238216 (1963, 1966 both to Janssen). HPLC determn: A. H. Hikal, H. I. Al-Shoura, J. Liq. Chromatogr. 5, 2205 (1982). Metabolism in rat: J. P. P. Heykants, Life Sci. 8, Part I, 1029 (1969). Pharmacology: P. A. J. Janssen et al., Arzneim.-Forsch. 20, 1689 (1970). Calcium channel blocking activity: R. J. Gould et al., Proc. Natl. Acad. Sci. USA 80, 5122 (1983); J. P. Galizzi et al., ibid. 83, 7513 (1986). Clinical trials in schizophrenia: H. Immich et al., Arzneim.-Forsch. 20, 1699 (1970); G. Chouinard et al., J. Clin. Psychopharmacol. 6, 21 (1986).
CAS Name: 5-[(Methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-2-oxazolidinone
Additional Names: 5-[(methylthio)methyl]-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinone; 5-(methylmerca...
Literature References: Prepn: BE 635608 (1963 to Polichimica SAP), C.A. 61, 16069c (1964), corresp to GB 969126.
CAS Name: 1-[2-(Hexahydro-1H-azepin-1-yl)ethyl]-2-oxocyclohexanecarboxylic acid phenylmethyl ester
Additional Names: 2-(b-hexamethyleniminoethyl)cyclohexanone-2-carboxylic acid benzyl ester
...
Literature References: Prepn: BE 639472; BE 639473; Frank et al., AT 237593 (all 1964 to Biochemie GmbH), C.A. 62, 5207e (1965).
CAS Name: a-(4-Chlorophenyl)-2-benzofuranmethanol
Additional Names: 2-benzofuryl-p-chlorophenylcarbinol
Trademarks: Menacor (Menarini)
Percent Composition: C 69.64%, H 4.29%, Cl 13.70%, O...
Literature References: Prepn: BE 644176; Ghelardoni, Russo, GB 1160925 (1964, 1969 both to Menarini), C.A. 63, 8319h (1965); 71, 124212f (1969); Ghelardoni, Russo, Boll. Chim. Farm. 109, 48 (1970). Pharmacology of the hemisuccinate deriv: Pisanti, Volterra, Farmaco Ed. Sci. 26, 312 (1971).
CAS Name: 3-Pyridinecarboxylic acid (2-hydroxy-1,3-cyclohexanediylidene)tetrakis(methylene) ester
Additional Names: nicotinic acid 1,1,3,3-tetraester with 2-hydroxy-1,1,3,3-cyclohexanetetrameth...
Literature References: Prepn: BE 658422 corresp to Irikura et al., US 3299077 (1965 and 1967 to Kyorin). Hypocholesterolemic action studies: Aso et al., J. Atheroscler. Res. 10, 391 (1969). Acute toxicity data: T. Sugawara et al., Oyo Yakuri 14, 741 (1977), C.A. 88, 131005v (1977). Review: Jpn. Med. Gaz. 8(8), 9 (1971).
CAS Name: 1-[2-[4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl]ethyl]-3-methyl-2-imidazolidinone
Additional Names: 3-chloro-10-[g-[N'-[b-(1-methyl-2-oxoimidazolidin-3-yl)ethyl]-N-p...
Literature References: Prepn: BE 668972 (1965 to Asta), C.A. 65, 8934f (1966).
CAS Name: 3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one
Additional Names: 3-ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)indol-4(5H)-one
Percent Composition: C...
Literature References: Prepn: BE 670798; I. J. Pachter, K. Schoen, US 3491093 (1966, 1970 both to Endo). Pharmacology: Sugerman, Herrmann, Clin. Pharmacol. Ther. 8, 261 (1967); Claghorn, Curr. Ther. Res. 11, 524 (1969); Guerrero-Figueroa et al., ibid. 15, 508 (1973). Toxicity study: E. I. Goldenthal, Toxicol. Appl. Pharmacol. 18, 185 (1971).
CAS Name: 1-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]piperazine
Additional Names: 1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)piperazin...
Literature References: Prepn: BE 730345; C. P. Fauran et al., US 3634411 (1969, 1972 both to Delalande); C. P. Fauran, M. J. Turin, Chim. Ther. 4, 290 (1969). Pharmacology: G. Huguet et al., ibid. 293; E. Marmo et al., Farmaco Ed. Prat. 28, 132 (1973); B. M. Pourrias et al., Therapie 29, 29, 43 (1974).
CAS Name: 3,4,5-Trimethoxy-N-3-piperidinylbenzamide
Additional Names: 3-(3,4,5-trimethoxybenzamido)piperidineTrademarks: Aplace (Kyorin)
Percent Composition: C 61.21%, H 7.53%, N 9.52%, O 21...
Literature References: Prepn: BE 736840; T. Irikura et al., US 3647805 (1969, 1972 both to Kyorin). Anti-ulcer activity: T. Irikura, K. Kasuga, J. Med. Chem. 14, 357 (1971). Pharmacokinetics in man: T. Irikura et al., Iyakuhin Kenkyu 12, 971 (1981), C.A. 96, 79377s (1982). Effect on gastric mucosa in rats: Y. Abe et al., Nippon Yakurigaku Zasshi 83, 317 (1984), C.A. 101, 456g (1984); on glucosamine synthetase: Y. Abe et al., Oyo Yakuri 27, 521 (1984), C.A. 101, 17001c (1984). Metabolism in rats: K. Tagaki et al., ibid. 1151, C.A. 101, 103555t (1984); K. Tagaki, K. Endo, ibid. 1167, C.A. 101, 103556u (1984). Toxicity: T. Irikura et al., Kiso to Rinsho 12, 3422 (1978).
CAS Name: 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
Additional Names: (±)-2-(2,2-diphenylcyclopropyl)-2-imidazoline; 1-(2-D2-imidazolinyl)-2,2-diphenylcyclopropane; cibenzolineP...
Literature References: Prepn: BE 807630; J. C. Cognaco, US 3903104 (1974, 1975 both to Hexachemie). Activity and tolerance: D. Herpin et al., Acta Cardiol. 36, 131 (1981). Electrophysiological effects in man: J. F. Thizy et al., Lyon Med. 245, 119 (1981). Clinical trial: D. Herpin et al., Curr. Ther. Res. 30, 742 (1981).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
